Uremic lung.
Grassi V, Malerba M, Boni E, Tantucci C, Sorbini CA.
Contrib Nephrol. 1994;106:36-42. doi: 10.1159/000422922.
Complement system activation: bridging physiology, pathophysiology, and therapy.
Azoulay E, Zuber J, Bousfiha AA, Long Y, Tan Y, Luo S, Essafti M, Annane D.
Intensive Care Med. 2024 Nov;50(11):1791-1803. doi: 10.1007/s00134-024-07611-4. Epub 2024 Sep 10.
The genus Aeromonas: taxonomy, pathogenicity, and infection.
Janda JM, Abbott SL.
Clin Microbiol Rev. 2010 Jan;23(1):35-73. doi: 10.1128/CMR.00039-09.
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.
Garred P, Tenner AJ, Mollnes TE.
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
Renal-pulmonary crosstalk.
Singbartl K.
Contrib Nephrol. 2011;174:65-70. doi: 10.1159/000329237. Epub 2011 Sep 9.
[Uremic lung].
Ogushi F, Ogura T.
Ryoikibetsu Shokogun Shirizu. 1994;(4):770-3.
Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.
Dilorenzo G, Telegrafo M, Marano G, De Ceglie M, Stabile Ianora AA, Angelelli G, Moschetta M.
Respir Med Case Rep. 2016 Oct 6;19:159-161. doi: 10.1016/j.rmcr.2016.10.003. eCollection 2016.
[Uremic lung].
Joko T, Hirakata H.
Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):69-71.
The survival of B cells is compromised in kidney disease.
Peroumal D, Jawale CV, Choi W, Rahimi H, Antos D, Li DD, Wang S, Manakkat Vijay GK, Mehta I, West R, Thangaraju M, Nolin TD, Das J, Alcorn JF, Biswas PS.
Nat Commun. 2024 Dec 30;15(1):10842. doi: 10.1038/s41467-024-55187-w.
Rapidly progressive glomerulonephritis.
Pollak VE, Mendoza N.
Med Clin North Am. 1971 Nov;55(6):1397-415. doi: 10.1016/s0025-7125(16)37245-5.
